[Brief interdisciplinary oncology: a model for ambulatory, multimodal treatment of tumor patients].
Since 10/1994 the Interdisziplinäre Kurzzeit-Onkologie (IKO) is an outpatient department for the treatment of patients with cancer used by the departments of hematology/oncology and surgery. Between 09/1995 and 02/1997, 818 patients received 2024 cytotoxic therapies with neoadjuvant (15%), adjuvant (65%) or palliative (20%) intention-mostly within multicenter clinical studies. Ambulatory operations like removal of lymph nodes for diagnosis or the implantation of venous catheter systems prepared the way for specialized modalities of cancer therapy. The high compliance and consent of patients, combined with better understanding of cancer therapy, resulted in an enhanced quality of life and optimized therapy. Standardization in diagnostics and fast realisation of interdisciplinary treatment schedules lead to reduction of costs and to enhancement of quality and security in cancer therapy.
Liersch
T
T
Abteilung Allgemeinchirurgie, Zentrum Chirurgie, Universitätsklinikum Göttingen.
Wörmann
B
B
Rauschecker
H F
HF
Kaufmann
C C
CC
Hiddemann
W
W
Becker
H
H
Gatzemeier
W
W
D000553:Ambulatory Care / Q000191:economics*; D003131:Combined Modality Therapy; D003362:Cost-Benefit Analysis; D005858:Germany; D006801:Humans; D009369:Neoplasms / Q000191:economics / Q000628:therapy*; D010166:Palliative Care / Q000191:economics; D010342:Patient Acceptance of Health Care; D010348:Patient Care Team / Q000191:economics*; D011788:Quality of Life
Interdisziplinäre Kurzzeit-Onkologie (IKO): Ein Modell zur ambulanten, multimodalen Behandlung von Tumorpatienten.